Technical Analysis for ASMB - Assembly Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 12.65 | -5.31% | -0.71 |
Earnings due: May 2
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| 50 DMA Support | Bullish | -5.31% | |
| Gapped Down | Weakness | -5.31% | |
| NR7 | Range Contraction | -4.67% | |
| Narrow Range Bar | Range Contraction | -4.67% | |
| New Downtrend | Bearish | -4.31% | |
| Gapped Up | Strength | -4.31% | |
| 20 DMA Resistance | Bearish | -5.67% |
| Alert | Time |
|---|---|
| Lower Bollinger Band Support | about 18 hours ago |
| Fell Below Lower Bollinger Band | about 18 hours ago |
| Down 10% | about 18 hours ago |
| Down 5% | about 18 hours ago |
| Down 1 ATR | about 18 hours ago |
Get a Trading Assistant
- Earnings date: 05/02/2024
Assembly Biosciences, Inc. Description
Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Gastroenterology Digestive System Surgery Digestive System Phenylephrine Fecal Incontinence Gastrointestinal Products Large Intestine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.04 |
| 52 Week Low | 7.692 |
| Average Volume | 19,652 |
| 200-Day Moving Average | 11.27 |
| 50-Day Moving Average | 13.03 |
| 20-Day Moving Average | 13.82 |
| 10-Day Moving Average | 13.51 |
| Average True Range | 0.78 |
| RSI (14) | 41.18 |
| ADX | 26.53 |
| +DI | 15.93 |
| -DI | 25.71 |
| Chandelier Exit (Long, 3 ATRs) | 12.85 |
| Chandelier Exit (Short, 3 ATRs) | 14.34 |
| Upper Bollinger Bands | 15.28 |
| Lower Bollinger Band | 12.36 |
| Percent B (%b) | 0.1 |
| BandWidth | 21.12 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.23 |
| MACD Histogram | -0.2038 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 14.79 | ||||
| Resistance 3 (R3) | 14.81 | 14.12 | 14.43 | ||
| Resistance 2 (R2) | 14.12 | 13.57 | 14.11 | 14.31 | |
| Resistance 1 (R1) | 13.38 | 13.24 | 13.04 | 13.36 | 14.19 |
| Pivot Point | 12.69 | 12.69 | 12.52 | 12.68 | 12.69 |
| Support 1 (S1) | 11.96 | 12.15 | 11.61 | 11.94 | 11.11 |
| Support 2 (S2) | 11.27 | 11.81 | 11.26 | 10.99 | |
| Support 3 (S3) | 10.53 | 11.27 | 10.87 | ||
| Support 4 (S4) | 10.51 |
